Chickenpox typically presents with a red, itchy rash that progresses to fluid-filled blisters, eventually crusting over. It is often accompanied by fever, fatigue, and headache. The rash usually starts on the face, chest, and back before spreading to the rest of the body.

Shingles presents as a painful, localized skin rash with blisters, often in a single stripe on one side of the body. It may be preceded by tingling or burning sensations. Other symptoms can include fever, headache, and fatigue.

Diagnosis of HHV-3 is primarily clinical, based on the characteristic appearance of the rash. Laboratory tests can confirm the diagnosis, including:

• Polymerase Chain Reaction (PCR): Detects viral DNA in skin lesions or blood.
• Direct Fluorescent Antibody (DFA) Test: Identifies viral antigens in skin scrapings.
• Serology: Measures antibodies to VZV, useful in determining immunity.

Treatment is mainly supportive, focusing on relieving symptoms. Antihistamines can reduce itching, and acetaminophen can manage fever. Antiviral medications like acyclovir may be prescribed for severe cases or at-risk individuals.

Antiviral medications (e.g., acyclovir, valacyclovir) are most effective when started within 72 hours of rash onset. Pain management is crucial, often requiring analgesics or nerve pain medications. Corticosteroids may be used in some cases to reduce inflammation.

Chickenpox is generally mild in children, with full recovery expected. Complications are rare but can include bacterial infections, pneumonia, and encephalitis.

Shingles can lead to complications such as postherpetic neuralgia (persistent pain after rash resolution) and, rarely, vision or hearing problems. Early treatment reduces the risk of complications.

HHV-3 is a highly contagious virus transmitted through respiratory droplets or direct contact with fluid from blisters. After initial infection (chickenpox), the virus remains dormant in nerve tissues and can reactivate later in life as shingles.

Chickenpox is common worldwide, primarily affecting children under 10. Vaccination has significantly reduced its incidence. Shingles is more common in older adults and those with weakened immune systems, with about one-third of people experiencing it in their lifetime.

After initial infection, HHV-3 travels through the bloodstream to the skin, causing chickenpox. The virus then becomes latent in nerve cells. Reactivation, often due to stress or immune suppression, leads to shingles, with the virus traveling along nerves to the skin.